epigenetic reprogramming – Talk Bio

Actionable Insights Powered by AI

Life Biosciences Appoints Industry Veteran David Guyer, M.D. to Board of Directors

3 weeks ago talkbio0Tagged Aging, Biotechnology, board of directors, cellular rejuvenation, David Guyer, Drug Development, epigenetic reprogramming, ER-100, Life Biosciences

Life Biosciences; David Guyer; Board of Directors; biotechnology; cellular rejuvenation; epigenetic reprogramming; ER-100; aging; drug development

Brian Armstrongs NewLimit raises a $130M Series B, laying out road map for anti-aging drugs

7 months ago talkbio0Tagged Brian Armstrong, CEO, Coinbase, epigenetic reprogramming, genetic cell, healthy lifespan, Kleiner, NewLimit, Perkins, Series B

NewLimit, Brian Armstrong, Coinbase CEO, anti-aging drugs, epigenetic reprogramming, Series B funding, Kleiner Perkins, genetic cell programming, healthy lifespan extension